Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

NUR 611 Adv Practice Nursing 1 NUR_6111_Week_2_GI_Disorders, Exams of Nursing

NUR 611 Adv Practice Nursing 1

Typology: Exams

2024/2025

Available from 09/03/2024

star_score_grades
star_score_grades 🇺🇸

3.6

(19)

1.7K documents

1 / 30

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Cholecystitis
Inflammation of the gallbladder, usually associated with gallstone disease, can be
acute or chronic
Gallstones obstruct the gallbladder-cystic duct junction, resulting in
inflammation and acute pain
In some cases, calculous cholecystitis, or gallbladder inflammation
without stones, is more common than obstruction of the common bile
duct.
Increases with age and BMI, most common in ages 50-70 years
Females > males (2:1)
4 F’s (Female, Fair, Fat, Forty-Fifty)
Increased incidence in Native Americans
Types
Classic obstruction - cystic duct or junction obstruction - mild WBC
elevation, bilirubin normal, amylase/lipase normal, LFT’s slight elevation
Bile duct obstruction - WBC elevation, bilirubin elevated, amylase/lipase
elevated, LFT’s normal
Pancreatic duct obstruction - WBC elevation, bilirubin elevated,
amylase/lipase elevated, LFT’s elevated
Risk Factors
Pregnancy
Rapid weight loss (e.g., bariatric surgery)
Obesity
Gallstones
Surgery or trauma
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e

Partial preview of the text

Download NUR 611 Adv Practice Nursing 1 NUR_6111_Week_2_GI_Disorders and more Exams Nursing in PDF only on Docsity!

● Cholecystitis ○ Inflammation of the gallbladder, usually associated with gallstone disease, can be acute or chronic ■ Gallstones obstruct the gallbladder-cystic duct junction, resulting in inflammation and acute pain ■ In some cases, calculous cholecystitis, or gallbladder inflammation without stones, is more common than obstruction of the common bile duct. ■ Increases with age and BMI, most common in ages 50-70 years ● Females > males (2:1) ● 4 F’s (Female, Fair, Fat, Forty-Fifty) ■ Increased incidence in Native Americans ○ ○ TypesClassic obstruction - cystic duct or junction obstruction - mild WBC elevation, bilirubin normal, amylase/lipase normal, LFT’s slight elevation ■ Bile duct obstruction - WBC elevation, bilirubin elevated, amylase/lipase elevated, LFT’s normal ■ Pancreatic duct obstruction - WBC elevation, bilirubin elevated, amylase/lipase elevated, LFT’s elevated ■ ○ Risk Factors ■ Pregnancy ■ Rapid weight loss (e.g., bariatric surgery) ■ Obesity ■ Gallstones ■ Surgery or trauma

■ Sickle cell anemia ■ Parental feeding over a prolonged period ■ Family history of gallstones ○ Clinical Presentation ■ typically present with RUQ pain, nausea, and vomiting ■ Pain may radiate from the shoulder to the scapula ■ Fever may or may not be present ○ Assessment ■ Subjective ● RUQ pain that is steady and severe, whose onset may have been gradual or sudden with radiation to the right shoulder or back, and has lasted at least 4-6 hours ● May report fever ● c/o nausea/vomiting ● c/o anorexia ● May report that pain started after a meal, particularly a fatty meal, one or more hours before the onset of pain ■ Objective ● Appears ill ● May be febrile ● May be tachycardic ● Abdominal guarding ● + Murphy’s sign (to perform, have the patient take a deep breath while palpating the area of gallbladder/ With acute choley, the patient will respond to pain by catching their breath) is considered highly sensitive ● May have a palpable RUQ mass ○ Differentials Diagnosis ■ Biliary colic-mild intermittent complaints ■ Peptic ulcer disease ■ Cardiac disease ■ Pancreatitis ■ Hepatitis ■ Bowel obstruction ■ Appendicitis ■ Right-sided pneumonia ○ Diagnostics ■ Labs ● CBC - leukocytosis ● CMP ● Bilirubin ● Liver Function Tests (LFT) - ALT/AST & ALP ● Amylase ● Lipase

○ Incidence ■ Acute diverticulitis is the third most common inpatient GI diagnosis in the US ■ The most frequently listed GI diagnosis in Outpatient clinics and ERs ■ Annual Cost $2.1 Billion ○ Prevalence ■ The prevalence of diverticulosis increases with age ■ 60% by age 60 years ■ The prevalence has been rising over the past few years ■ 180/100,000 people per year ■ Men > women ■ More complications in people who smoke ■ More common where there are low-fiber dietary habits ○ Clinical Presentation ■ Abdominal Pain Most Common ( LLQ ) 70% of patients ■ Nausea and vomiting ■ Anorexia ■ Constipation, obstipation, or diarrhea ■ Fever, Leukocytosis, and chills ■ Flatulence, bloating, gas abdominal distention ■ Board-like rigidity and rebound tenderness ■ Presence of fistulas ■ Unremarkable findings on PE ■ Urinary complaints - *urinary retention or dysuria ■ Signs of peritoneal infection/requires hospitalization ○ Common Differential Diagnosis ■ Inflammatory bowel disease ■ Appendicitis ■ Infectious Colitis ■ Ischemic Colitis ■ Colorectal cancer ■ Irritable Bowel Syndrome (IBS) ■ Gynecological disorders ■ Urological disorders ■ Lactose intolerance ○ Diagnostic StudiesAbdominal CT with or without contrast ■ Barium Enema - used to diagnose diverticulosis ■ CBC : leukocytosis ■ Electrolytes *deficiency from diarrhea or vomiting ■ Urinalysis *may show blood or, eventually, a UTI ■ Pregnancy test, if clinically indicated ■ SED rate elevated ■ Colonoscopy/flexible sigmoidoscopy

■ Colonoscopy recommended 4-6 weeks after resolution of symptoms ○ Management ■ Management depends on the severity, presence of complications, and comorbidity ■ There is no standard management in the treatment of diverticular diseases, including diverticulitis ■ Use of antibiotics selectively rather than routinely ■ A colonoscopy should be performed after resolution of acute diverticulitis ■ Advise patients to avoid routine use of aspirin and NSAIDs ○ Pharmacological TreatmentCiprofloxacin 500 mg q 12 hours & Metronidazole 500 mg q 8 hours x 7-10 days OR ■ Bactrim 800/160 mg 1 DS q 12 hours & Metronidazole 500 mg q 8 hours x 7-10 days OR ■ Augmentin 875/125 mg q 8 hours for 7-10 days ■ *Take with food ■ For patients intolerant of both Metronidazole and beta-lactam agents ● Moxifloxacin 400 mg daily for 7-10 days ○ Nonpharmacological Management ■ Bowel Rest; Clear liquids 2-3 days ■ Advance to a soft or regular diet as tolerated ■ Restricting seeds, nuts, corn, and popcorn is controversial ■ Recommend high-fiber diet ■ Regular exercise or activity ■ Avoid NSAIDs in flares ■ Follow up 2-3 days after initiating treatment ■ GI referral colonoscopy 6-8 weeks after resolution of symptoms ■ Surgery may be indicated if there are frequent recurrences ○ Refer for inpatient treatment ■ Severe abdominal pain and or fever persists despite 2 days of oral antibiotics ■ Inability to tolerate PO fluids ■ Inpatient treatment consists of ● NPO or clear liquids ● IVF ● IV broad-spectrum antibiotics ● Pain control ● CT to exclude abscess or perforation ● Surgical Resection ○ Geriatric Considerations ■ Prevalence increases to 50-70% in those aged over 80 years ■ Diagnosis and treatment for the elderly are more complicated due to more comorbid conditions.

● Exposure to sunlight. ○ Etiology ■ The primary cause is unknown ■ Secondary multifactorial causes: ● Genetic predisposition- (hereditary) ● Epithelial barrier defects- When irritation and swelling lead to ulcers and open sores in the lining. ● Dysregulated immune responses. When the body mistakenly attacks itself, causing inflammation in the inner lining of your colon. ● Environmental factors: Bacteria, viruses, and antigens may trigger your immune system. ○ UC ■ Frequent diarrhea, with or without blood ■ Ranging from mild abdominal to severe abdominal pain and cramping ■ Intermittent constipation ■ Fatigue ■ Low to high fever ■ Tachycardia ■ Weight loss ○ Crohn’s ■ cramping sensation/intermittent or constant ■ Fatigue ■ Weight loss ■ Fever ■ Prolonged diarrhea ■ Occasional blood on stools ■ Ulcers of the intestines or mouth ■ Fistulas ■ Joint swelling ○ Assessment ■ Abdominal tenderness with distention and tympany on percussion. ■ Bleeding on rectal exam. ■ Anal fissures or skin tags may be present due to irritation from diarrhea. ■ Other symptoms due to inflammation: ● Pain/swelling of large joints: hips and knees. ● Itchy eyes or red spots on the skin. ○ Differentials ■ Infectious colitis or enteritis ■ Irritable bowel syndrome ■ Appendicitis ■ Peptic ulcer disease ■ Renal colic ■ Diverticulitis

■ Hyperthyroidism ■ Malabsorption disorders ■ Lactose intolerance ■ NSAID adverse effects ○ Diagnostics ■ CBC with differential ■ CMP, including LFTs, creatinine, glucose, Vitamin B12, and folate ■ C-reaction protein ■ Genetic testing ■ Stool test ● Culture and sensitivity ● Fecal leukocytes and calprotectin = inflammation in the bowels ■ Upper endoscopy with biopsy ■ Flexible sigmoidoscopy/ colonoscopy ■ CT scan of abdomen/ enterography ■ MRI of abdomen/ enterography ■ Barium xrays ■ Capsule endoscopy ○ Management ■ Pharmacological ● Corticosteroids – for inflammation ● Immunomodulators ● Biologics – to induce and maintain remission ● antibiotics – to treat infection ■ Non-pharmacological ● Maintain nutrition and weight: avoid food triggers, a low-fat diet, lactose, and low-fiber diet if strictures are present, and avoid caffeine, alcohol, nuts, and seeds. ● Stop smoking ● Exercise regularly and practice stress management ● Surgery when indicated: intestinal obstruction, bowel perforation, GI bleeding, enteric fistula refractory to medical therapy, small bowel or colon cancer ○ *People with Crohn’s disease are more likely to develop colon cancer. ○ Most cases are referred to GI for treatment and management ● Hepatitis ○ What is Hepatitis? ■ Acute or Chronic Inflammation of the liver caused by ● Viruses, alcohol, medications, autoimmune disease, metabolic defects ■ Inflammation >6 months is considered chronic liver disease (CLD) ■ Hepatitis has a high incidence of progression to Cirrhosis and ■ Liver failure and the need for transplantation may occur

■ Vomiting ■ Abdominal pain ■ Weight loss ■ ■ ○ Physical Exam ■ Jaundice ■ Dark Urine ■ Cutaneous angiomas ■ Ascites ■ Prominent dilated veins, especially to the abdomen if ascites present ■ Tender or enlarged liver, normal 6-12cm ● *Mean liver span is 10.5cm for males and 7 cm for females; the liver palpated more than 1-2cm below the right coastal margin is enlarged ■ Mild to moderate dull pain in RUQ or epigastrium ■ Anorexia, nausea, malaise, and low-grade fever ■ Needle tracks- hands, arms, and antecubital fossae

○ Acute Hepatitis Diagnostics ■ CBC – leukocytosis, anemia (especially if it is alcoholic hepatitis) ■ CMP - elevated ALT and AST, bilirubin and alkaline phosphatase may be elevated, low albumin, abnormal glucose, electrolyte imbalances ■ ESR, CRP – elevated ■ PT, PTT, INR - Abnormal ■ Elevated ammonia - neurologic symptoms (*hepatic encephalopathy - it is a big indicator of hepatic failure) ○ Diagnostic Testing ■ Ultrasonography- the most cost-effective. ■ Computed tomography- shows the presence of tumor, fatty tissue, and liver size ■ Magnetic resonance cholangiopancreatography ■ Liver Biopsy if diagnosis is inconclusive (ultrasound or CT guided) ■ A CT scan of the upper abdomen shows a fatty liver ○ Laboratory Testing ■ Serologic tests for acute infections: ● Hepatitis A: IgM anti-HAV ● Hepatitis B: HBsAg, plus IgM anti-HBc ● Hepatitis C: No serologic marker for acute infection ■ Serologic tests for chronic infections: ● Hepatitis A: Not applicable—no chronic infection ● Hepatitis B: Tests for chronic infection should include three HBV seromarkers: HBsAg, anti-HBs, and Total anti-HBc

■ Wilson's disease ■ Cystic fibrosis ■ Other viral infections (EBV, CMV, coxsackievirus herpes) ■ Acute cholangitis (infection of the bile duct) ■ Drug toxicity and poisoning ■ Hepatic malignancy ■ Autoimmune, alcoholic, or ischemic hepatitis ■ Acute cholecystitis ■ Disseminated sepsis ○ HCV Screening ■ The USPSTF recently expanded screening recommendations to all adults aged 18 to 79 years ■ There needs to be a focus on low-income, uninsured, and underserved populations where screening has remained low ■ Stigmatization, anxiety, and patient labeling discourage people from getting screening for HCV ○ Prevention and Pharmacological Interventions

○ Pharmacological Symptom Management ■ Cholestyramine (Questran) for pruritus associated with Jaundice- 1 packet/ scoop (5 mg) mixed with food or fluids BID ■ Acetaminophen overdose, N-Acetylcysteine- oral regimen (Mucomyst) or IV formulation (Acetadone) ■ Rifaximin 550 mg PO every 12 hours, along with a large dose of lactulose for hepatic encephalopathy ■ No pharmacological treatment for NAFLD, prevention, and control of metabolic disorders is imperative ○ Evidenced-Based Treatment Approach: Non-Pharmacological ■ Education ■ Vaccinate against other viral hepatitis infections ■ Abstain from alcohol ■ Avoid large doses of hepatotoxic drugs (acetaminophen, iron, etc.) ■ Refrain from starting new medications ■ Acute hepatitis ● High-calorie diet (best tolerated in the morning), maintain fluid balance ● Monitoring of clotting factors, liver function, and metabolic disease ■ Chronic hepatitis ● Serology, radiology, or pathology testing ● Screening/monitoring for HHC: liver ultrasound/biopsy ● Vaccination against pneumococcal infections ○ Geriatric Considerations ■ Liver size decreases by 25% between the ages of 20 and 70 years. ■ Drug metabolism by the liver is impaired. ■ Prolonged liver metabolism causes increased side effects. ■ Polypharmacy has a high risk of drug-drug interaction with antiviral drugs. ○ Follow up ■ HAV 6 to 12 months after acute illness; measure LFTs

■ Overweight/obesity ■ Lifestyle: ● Alcohol, caffeine, smoking, carbonated beverages, eating before sleeping, fatty/fried foods, spicy foods, overly processed foods ■ Medication (i.e.: Calcium channel blockers, NSAID’s) ■ Hormones ■ Aging ■ Increased acid secretion ■ Pregnancy ■ DM - diabetic gastroparesis ■ Disease process – gastritis, H.Pylori, Cancer ○ Clinical Presentation ■ Typical ● Heartburn ● Regurgitation Bad taste ■ Atypical ● Dysphagia ● Non-cardiac chest pain ● hypersalivation ● Globus sensation ● Odynophagia (Painful swallowing) ● Epigastric fullness/pain ● Dyspepsia ● Nausea ● Bloating ■ Extraesophageal ● Dental erosions ● Sore throat ● Laryngitis ● Hoarseness ● Chronic cough ● Wheezing ● Asthma ● Bronchospasm ○ Physical Exam ■ Careful history is likely to be more important than the physical findings in GERD ● dental erosions, loss of enamel and exposed dentin, Halitosis ● Cutaneous evidence of smoking, scleroderma, evidenced as thickened, tight, shiny skin or sclerodactyly as well as facial telangiectasia ● Weight loss is a concern - particularly with dysphagia

● Respiratory wheezes and coughs may be seen if there is associated asthma ● Epigastric tenderness or Hemoccult-positive stool may be the result of esophageal erosions, ulcerations, or even severe inflammation ● Any abdominal mass is suggestive of malignant neoplasia ○ Diagnosis ■ Patient with classic symptoms and no red flags can be diagnosed with presumptive GERD ■ Patient’s with not enough information, atypical symptoms or red flags need further evaluation to rule out other diagnosis before diagnosing GERD ■ Referral to GI for endoscopy or further testing may be warranted. ■ Primary Care ● CBC ● CMP ● H. pylori (breath or blood) ● Stool testing ■ Specialty ● Endoscopy ● Barium Esophagram (swallow) ● HRM ● 24 or 48 hr. PH scan by transnasal catheter or radiotelemetry capsule ● EndoFLIP ● Gastric scintigraphy ● Gastric emptying scan ○ Differential Diagnosis ■ Infectious esophagitis ■ Pill esophagitis ■ Eosinophilic esophagitis ■ Esophageal CA ■ Esophageal motility disorder ■ Esophageal rings w/ webs ○ Treatment Goals ■ Symptom control ■ Esophageal mucosal healing ■ Prevention of complications (eg strictures, Barrett's esophagus, CA) ○ Complications ■ Esophageal ● Barrett's esophagus ● Esophageal stricture ● Esophageal carcinoma ■ Extra-esophageal

■ Individuals who fail to respond to once-daily PPI therapy OR ■ Can’t tolerate long-term PPIs OR ■ Want to discontinue therapy ○ Endoscopic Correction (considered experimental) ■ Linx ● A small expandable ring of magnetically linked beads is placed in the distal esophagus to hold the les CLOSED WHEN NOT SWALLOWING ● ■ Stretta ● A catheter is positioned and needles are inserted into the muscles at the gastroesophageal junction. Radiofrequency is used to create thermal lesions thought to thicken the sphincter ○ Surgical Intervention ■ Nissen Fundoplication ● The laparoscopic procedure was developed in 1991 and is considered the standard – fewer complications than an open procedure ● ● Hemorrhoids ○ Used to be called "piles.” ○ Patients will often not disclose - ask! ○ There are management techniques ○ Literally causes “pain in the ___.” ○ Hemorrhoidal veins are normal anatomic structures located in the submucosal layer in the lower rectum ○ There are internal, external, and mixed hemorrhoids ○ Equal in both sexes, peak ages 45 to 65 ○ Cardinal features are bleeding, anal pruritus, prolapse, and pain ○ External ■ Located in the skin around the anus ● Itching or irritation in your anal region

● Pain or discomfort ● Swelling around your anus ● Bleeding ○ Internal ■ lie inside the rectum. Patient may not be able to see or feel them ● Rarely cause discomfort. But straining or irritation can cause symptoms ● Painless bleeding during bowel ● A hemorrhoid to push through the anal opening (prolapsed or protruding hemorrhoid) ○ resulting in pain and irritation. ○ Thrombosed ■ blood pools in an external hemorrhoid and forms a clot (thrombus). ● Severe pain ● Swelling ● Inflammation ● A hard lump near the anus ○ ○ ○ Risk Factors ■ Pregnancy ■ Hypertension, heart failure ■ Prolonged sitting ■ Obesity ■ Low-fiber diets ■ Lifting heavy weights ■ Aging ■ Straining with defecation